10.1111/dom.16364 Summary Keywords tirzepatide, rhabdomyolysis, GLP-1 receptor agonist, adverse drug reaction, muscle injury Citation Bodanowitz JM, Mattes I, Loebermann M and Fritzsche C (2025) Case Report: Rhabdomyolysis following initiation of tirzepatide
Metabolic enhancement: Lipotropics and B12 work together to improve the body's ability to convert fats and proteins into energy
The C-terminal domain contributes, together with the N-terminal domain, to shaping the co-substrate binding site, which is termed H-site, from the hydrophobic nature of co-substrates
Selection Bias: While baseline characteristics were generally well-balanced (24/24 Low risk), details regarding sequence generation (22/24 Unclear) and allocation concealment (24/24 Unclear) were largely missing, leading to a predominance of Unclear risk in the selection process
Potential Benefits: Enhanced Skin Health and Appearance: Each component contributes to healthier, more resilient skin with reduced signs of aging
Trong mt s trng hp c bit v thi gian ngn, vitamin C c th c s dng vi liu cao hn nhu cu khuyn ngh, nhng cn c nhn ha liu dng v c s t vn ca bc s
